Clinical Trial

Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of our study is to evaluate temporomandibular joint (TMJ), cervical posture, balance, dual-task performance, and social adaptation skills in individuals with autism. The study will be conducted at Bartın Lider Special Education and Rehabilitation Center following the approval of the ethics committee. Individuals determined by the sample size calculated through power analysis will be included in the study. First, the socio-demographic characteristics (age, height, body weight, body mass index, education level, exercise and smoking habits, etc.) of the participants who voluntarily join the study will be recorded. Participants will be divided into two groups: individuals with typical motor development and those with autism spectrum disorder (ASD), and the same assessment tools will be used for both groups. Individuals with typical motor development will serve as the control group. The assessment tools include the Timed Up and Go (TUG) test, the 10-Meter Walk Test, the Vineland Adaptive Behavior Scale, the PostureScreen Android-based posture assessment application, and the Helkimo Clinical Dysfunction Index for craniomandibular disorders. Based on the evaluation results, the relationships between TMJ, cervical posture, functional balance, dual-task performance, and social adaptation skills in individuals with autism will be analyzed and compared with those of individuals with typical motor development.
Trial Details
NCT Number NCT06721104
Lead Sponsor Kırıkkale University
Conditions Autism Spectrum Disorder, Temporomandibular Joint Disorders, Postural; Defect
Enrollment 23 participants
Start Date 2024-02-15
Primary Completion 2025-01-01 (estimated)
Study Completion 2025-05-25 (estimated)
Updated on ClinicalTrials.gov 2024-12-06